By: Akanksha
Three doctors from India’s leading health and medical institutes have been named among the world’s top 2% of scientists in General Clinical Medicine and Emergency and Critical Care Medicine. Compiled by a team led by Professor John P.A. Ioannidis of Stanford University in collaboration with Elsevier, the 2026 list recognizes their research contributions and ongoing impact in clinical medicine.
The 2026 Stanford University list of top cited scientists evaluated researchers using standardized data across several metrics:
Total citations
H-index and co-authorship-adjusted h-index
Citations per author position
A composite score(c-score)
Researchers qualify for the list if they rank among the top 100,000 scientists globally based on their c-score (evaluated both with and without self-citations), or if they place within the top 2% of their specific sub-field. Three doctors from India earned recognition across these clinical categories in the 2026 edition.
The database has two inclusion criteria. Researchers qualify if they rank among the top 100,000 scientists globally based on their composite score (c-score), calculated with or without self-citations, or if they fall within the top 2% of their respective sub-fields. Therefore, a scientist can have a global rank beyond 100,000 and still qualify through the sub-field percentile criterion.
The database classifies scientists into 20 broad scientific fields and 174 sub-fields using the Science-Metrix classification.
Three doctors from India earned recognition across the General Clinical Medicine and Emergency and Critical Care Medicine categories in the 2026 edition.
Dr. Dibyajyoti Banerjee serves as Professor and head of the Department of Experimental Medicine and Biotechnology at the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh. Included under the broad category of Clinical Medicine, his primary sub-field is General Clinical Medicine, and his secondary sub-field is Neurology and Neurosurgery. In the 2026 list, he ranked 885,096th globally based on his composite score (excluding self-citations). By the end of 2025, his h-index stood at 7, and he received 165 citations during 2025, excluding self-citations. His research centers on translational medicine, clinical biochemistry, and molecular diagnostics, with a focus on diabetic neuropathies, microalbuminuria detection methods, and the host defense systemic inflammatory response.
His published work includes:
Investigating the protective effects of Vitamin D in health, disease and COVID-19.
Evaluating whether dye-based methods are suitable for detecting microalbuminuria.
Developing a fluorometric method to specifically detect human serum albumin in urine using its pseudo esterase property.
Dr. Sheila Nainan Myatra practices in the Department of Anesthiology, Critical Care, and Pain at Tata Memorial Hospital, Homi Bhabha National Institute in Mumbai. Categorized under Clinical Medicine, her primary sub-field is Emergency and Critical Care Medicine, with a secondary sub-field in Anesthesiology. In the 2026 list, she ranked 112,059th globally based on her composite score (excluding self-citations). By the end of 2025, she achieved an h-index of 18 and accumulated 1,831 citations.
Her research focuses on airway management, mitigating risks for patients with difficult intubation, mechanical ventilation, sepsis, and infection control in the Intensive Care Unit (ICU). Additionally, she has led multi-center critical care studies and authored clinical guidelines for managing the physiologically difficult airway.
In 2025, she was among the authors of the All India Difficult Airway Association (AIDAA) guidelines covering the management of unanticipated difficult airways in adults, obstetrics, and pediatrics, as well as at-risk estuations. The guidelines provide recommendations for airway management in different clinical situations and were published in the Indian Journal of Anesthesia.
Dr. Mohan Gurjar is a professor in the Department of Critical Care Medicine at the Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS) in Lukhnow. Like Dr. Myatra, his primary field is Clinical Medicine, with a first sub-field in Emergency and Critical Care Medicine and a second sub-field in Anesthesiology. He ranked 216,224th globally in the 2026 Stanford rankings based on his composite score (excluding self-citations). By the end of 2025, his h-index stood at 14, with 749 citations recorded in 2025.
At SGPGIMS, his clinical research focuses on severe sepsis, multi-organ dysfunction syndrome (MODS), acute respiratory failure, mortality prediction, and management of immunocompromised critically ill patients in tertiary care settings.
SGPGIMS also lists his research projects on biomarkers for predicting contrast-induced acute kidney injury in critically ill patients (2015–2017) and renal outcomes in acute kidney disease among critically ill patients (2018–2020).
Another project involved developing a portable, lightweight device for subglottic secretion drainage in collaboration with the Indian Institute of Technology (IIT) Kanpur between 2017 and 2019. IIT Kanpur's intellectual property records also list an Automated Subglottic Aspiration Device involving Dr. Gurjar.
(Rh/APC/MSM)